SCIENION and Applied Microarrays will offer joint services and equipment solutions, that will allow our customers to support all aspects of development, high volume manufacturing and launch of regulated IVD products.
"Our objectives are to enable our customers to achieve rapid time-to-market, and to increase their probability of success related to scaling the production of diagnostic devices. This partnership will facilitate a seamless integration of developmental work carried out at both our companies." SCIENION CEO Holger Eickhoff said.
"For us, working with the team at Applied Microarrays, means reaching a huge new audience of users who need affordable and effective tools to produce diagnostic devices. Many of our customers already work with both our companies. This partnership will enable those and future joint customers to interact and communicate seamlessly during development and manufacturing." Eickhoff said.
"A key factor for the growth of Applied Microarrays business has been the extension of our services to manage additional steps in our customers product development and supply chains. Our partnership with SCIENION will further expand the range of leadership deposition technologies we can apply across existing and future customer application areas. We expect the new joint service offering to be extremely well received by our customers." Applied Microarrays CEO Alastair Malcolm stated.